For instance, Zhang et al. reported higher ABCG2 expression in ER+ BC patients than in TNBC or HER2+ subtypes, with elevated ABCG2 correlating with larger tumor size, lymphatic spread, and poor pathological response [63]. Here, ERBB2 is linked to breast cancer.